|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 31.49 USD | +0.03% |
|
+0.06% | +34.92% |
| 07-16 | Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals | MT |
| 07-16 | Deals of the day-Mergers and acquisitions | RE |
| Market Cap | 3.85B 3.37B 3.11B 2.87B 5.4B 371B 5.52B 37.16B 14.61B 182B 14.48B 14.16B 626B | P/E 2026 * |
16.6x | P/E 2027 * | 13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 3.85B 3.37B 3.11B 2.87B 5.4B 371B 5.52B 37.16B 14.61B 182B 14.48B 14.16B 626B | EV / Sales 2026 * |
6.1x | EV / Sales 2027 * | 5.43x |
| Free-Float |
94.43% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Catalyst Pharmaceuticals, Inc.
| 1 day | +0.03% | ||
| 1 week | +0.06% | ||
| Current month | +0.19% | ||
| 1 month | +0.29% | ||
| 3 months | +19.92% | ||
| 6 months | +38.72% | ||
| Current year | +34.92% |
| 1 week | 31.47 |  | 31.5 |
| 1 month | 31.36 | | 31.5 |
| Current year | 22.13 | | 32.56 |
| 1 year | 19.05 | | 32.56 |
| 3 years | 11.55 | | 32.56 |
| 5 years | 4.81 | | 32.56 |
| 10 years | 0.68 | | 32.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Daly
CEO | Chief Executive Officer | 65 | 01/01/2024 |
Michael Kalb
DFI | Director of Finance/CFO | 55 | 01/01/2024 |
William Andrews
CTO | Chief Tech/Sci/R&D Officer | 62 | 01/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 48 | 15/07/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03/06/26 | Fiscal year | Chief Technology Officer | 3,795 | 0.0031% | ||
| 17/02/26 | Fiscal year | Head of Human Resources | 1,585 | 0.0013% | ||
| 05/01/26 | Fiscal year | Chief Executive Officer | 94,787 | 0.0771% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.03% | +0.06% | +46.81% | +133.78% | 3.85B | |
| -0.33% | +1.83% | +23.03% | -6.22% | 68.85B | |
| +0.67% | +0.93% | +37.53% | +198.53% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | |
| +1.12% | +0.35% | -50.35% | -52.35% | 41.24B | |
| -1.40% | +3.43% | +60.07% | -26.01% | 30.41B | |
| -2.11% | -9.45% | +91.99% | -49.58% | 24.53B | |
| +0.51% | +0.46% | +70.08% | +91.96% | 23.42B | |
| -5.57% | -0.84% | -0.17% | +174.11% | 19.75B | |
| -0.86% | -1.99% | +68.42% | +124.39% | 16.57B | |
| Average | -0.70% | -0.72% | +38.70% | +62.82% | 32.42B | |
| Weighted average by Cap. | -0.33% | -0.07% | +31.53% | +48.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 632M 552M 510M 470M 886M 60.88B 905M 6.09B 2.4B 29.82B 2.37B 2.32B 103B | 709M 620M 572M 527M 994M 68.32B 1.02B 6.84B 2.69B 33.46B 2.66B 2.61B 115B |
| Net income | 231M 202M 186M 172M 324M 22.26B 331M 2.23B 876M 10.9B 868M 849M 37.53B | 279M 244M 225M 207M 391M 26.85B 399M 2.69B 1.06B 13.15B 1.05B 1.02B 45.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/07/26 | $31.49 | +0.03% | 15,513,864 |
| 13/07/26 | $31.48 | +0.03% | 3,386,053 |
| 10/07/26 | $31.47 | 0.00% | 1,346,672 |
| 09/07/26 | $31.47 | 0.00% | 1,506,797 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- CPRX Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
